Nanotechnology for enhanced nose-to-brain drug delivery in treating neurological diseases
Q Huang, Y Chen, W Zhang, X Xia, H Li, M Qin… - Journal of Controlled …, 2024 - Elsevier
Despite the increasing global incidence of brain disorders, achieving sufficient delivery
towards the central nervous system (CNS) remains a formidable challenge in terms of …
towards the central nervous system (CNS) remains a formidable challenge in terms of …
The nanocarrier strategy for crossing the blood-brain barrier in glioma therapy
H Wu, Y Wang, Z Ren, H Cong, Y Shen, B Yu - Chinese Chemical Letters, 2024 - Elsevier
Glioma is the most common malignant tumor of the brain. The postoperative recurrence rate
was high, and the 2-year survival rate only increased by 20%–25%. The reason is the blood …
was high, and the 2-year survival rate only increased by 20%–25%. The reason is the blood …
Current Insights on Lipid-Based Nanosystems 2023
AC Silva, JN Moreira, JM Sousa Lobo - Pharmaceuticals, 2023 - mdpi.com
Among the different types of nanosystems that have been investigated for therapeutic use,
lipid-based ones are the most explored, as they have advantages over non-lipid …
lipid-based ones are the most explored, as they have advantages over non-lipid …